Some sequences in the genome cause genes to be switched on or off. Until now, each of these gene switches, or so-called enhancers, was thought to have its own place on the DNA.
IlluminaA 523-gene oncology panel identifies actionable tumor variations and improves outcomesA large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that ...
A 523-gene oncology panel identifies actionable tumor variations and improves outcomes ... is a powerful tool to direct patients to the most advanced precision therapies that improve overall survival.
Meanwhile, cannabis progress could stop under the Trump administration; a labeling issues prompts a recall of the popular drug Clonazepam; Novartis acquires Kate Therapeutics; and more. The Hill: FDA ...
Here, we used deep full-length single-cell RNA-sequencing to distinguish post-mitotic cone and rod developmental states and cone-specific features that contribute to retinoblastomagenesis. The ...
Researchers investigating ways to reduce exhaustion in cancer-fighting T-cells found that the Golgi apparatus can be used as a simple marker -- more Golgi means a more robust cell.